Status: Recruiting
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
The purpose of this research is to learn if the CellSearch Circulating Tumor Cells (CTC) test can help doctors in making decisions about treatment and monitoring of breast cancer. The test consists of diagnostic CTC counts (enumeration) and expression of biomarkers Human Epidermal growth factor Receptor 2 (HER2), Estrogen Receptor (ER), and programmed death-ligand 1 (PD-L1) and cell free DNA/RNA (cfDNA/RNA) analysis.
Participants needed: 187
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Menarini Silicon Biosystems, INCUpdated: Mar 18, 2026Locations: 1Duration: 24 Months
Eligibility criteria
Invasive breast cancer with radiographic and/or clinical evidence of advanced me... [+3]
Participant is pregnant. [+1]